N/A
N=24
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
Food Hypersensitivity
Bottom Line
View on ClinicalTrials.gov: NCT02350660 ↗Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcome: Primary: The Level of Allergen Consumed Post-oral Immunotherapy — 6; 300 milligrams
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- cow's milk (Dietary_supplement); peanut powder (Dietary_supplement)
- Age
- Pediatric, Adult, Older Adult · 4+ yrs
- Sex
- All
- Sponsor
- University of Virginia
- Primary completion
- Sep 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Level of Allergen Consumed Post-oral Immunotherapy |
6; 300 | — |
Summary
Pilot study to assess the effect of oral immunotherapy on specific Immunoglobulin E (IgE) levels and antigen consumption in two distinct food allergies.
Eligibility Criteria
Inclusion Criteria
- Presence or absence of specific IgE to alpha-gal or peanut
Exclusion Criteria
- History of severe anaphylaxis
- allergy to cow's milk protein
Data sourced from ClinicalTrials.gov (NCT02350660). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.